Publicacións nas que colabora con María Pérez Mato (12)

2024

  1. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

2022

  1. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

2021

  1. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage

    Translational Research, Vol. 230, pp. 68-81

  3. sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies

    Frontiers in Neurology, Vol. 12

2020

  1. NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack

    International Journal of Cardiology, Vol. 298, pp. 93-97

  2. Temperature-induced changes in reperfused stroke: Inflammatory and thrombolytic biomarkers

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-12

  3. The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 11, pp. 2103-2114

2019

  1. Blood glutamate EAAT2-cell grabbing therapy in cerebral ischemia

    EBioMedicine, Vol. 39, pp. 118-131

  2. Light-emitting diode photobiomodulation after cerebral ischemia

    Frontiers in Neurology, Vol. 10, Núm. AUG

2018

  1. Clinical validation of blood/brain glutamate grabbing in acute ischemic stroke

    Annals of Neurology, Vol. 84, Núm. 2, pp. 260-273

2016

  1. Potential protective role of endogenous glutamate-oxaloacetate transaminase against glutamate excitotoxicity in fetal hypoxic-ischaemic asphyxia

    Developmental Medicine and Child Neurology, Vol. 58, Núm. 1, pp. 57-62